Hua Medicine (2552) announced that its independent non-executive director, Mr. Yiu Leung Andy Cheung, has been appointed as a member of the Remuneration Committee effective November 27, 2025. Mr. Cheung’s other positions on the Board remain unchanged. According to the company, Mr. Cheung’s biographical details were set out in the 2024 annual report, with no additional updates disclosed.
Following this appointment, the Remuneration Committee is chaired by Mr. William Robert Keller and includes Mr. Yiu Wa Alec Tsui and Mr. Cheung. The Board expressed a warm welcome to Mr. Cheung in his new role.